Other
Neoplasm by Special Category
CI-CAN-00000004Explore in graph →
Non-malignant21,349 active trials259 approved drugs3,859 evidence items
- NCIt
- C7062
Loading cancer entity…
Other
CI-CAN-00000004Explore in graph →
Clinical trials
95,726 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06349044 | A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies. | unknown | N/A | 120 | Zhejiang Cancer HospitalOTHER | 1 | Aug 27, 2024 | clinicaltrials |
| NCT06573736 | Stockholm3 Use Prior to MRI for Prostate Cancer Detection in a Clinical Care Pathway: a Multi-centered Validation(S3M-MRI) | unknown | — | 500 | Karolinska Institutet |
| 0 |
| Aug 27, 2024 |
| clinicaltrials |
| NCT06573788 | Multidisciplinary Prehabilitation Management Pathway and Network Platform Construction | unknown | N/A | 64 | Peking Union Medical College HospitalOTHER | 0 | Aug 27, 2024 | clinicaltrials |
| NCT06574308 | Clinical Evaluation of the Scopio Cell Morphology Technology(Hemascopio) | unknown | — | 300 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Aug 27, 2024 | clinicaltrials |
| NCT03375437 | RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions.(RNASARC) | unknown | N/A | 376 | Centre Leon BerardOTHER | 1 | Aug 26, 2024 | clinicaltrials |
| NCT05176665 | EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers | unknown | Phase 1 / Phase 2 | 152 | Shanghai EpimAb Biotherapeutics Co., Ltd.INDUSTRY | 2 | Aug 26, 2024 | clinicaltrials |
| NCT05830097 | A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 260 | Coherent Biopharma (Hefei) Co., Ltd.INDUSTRY | 2 | Aug 26, 2024 | clinicaltrials |
| NCT06471673 | A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer | unknown | Phase 1 / Phase 2 | 18 | BriaCell Therapeutics CorporationINDUSTRY | 1 | Aug 26, 2024 | clinicaltrials |
| NCT06486545 | Liposomal Irinotecan Combination Regimen for Second-line Treatment of Advanced Gastric Cancer | unknown | N/A | 18 | Hunan Cancer HospitalOTHER | 0 | Aug 26, 2024 | clinicaltrials |
| NCT06569459 | Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the Treatment of Esophageal Cancer | unknown | Phase 2 | 60 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Aug 26, 2024 | clinicaltrials |
| NCT06570486 | Contrast Between Traditional Regression Model and AI in Predicting Prolonged Stay Stay After Head and Neck Tumors | unknown | — | 700 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Aug 26, 2024 | clinicaltrials |
| NCT06571396 | Perioperative Risk of Immunotherapy Based Neoadjuvant and Conversion Therapy for Hepatocellular Carcinoma | unknown | — | 200 | Qilu Hospital of Shandong UniversityOTHER | 1 | Aug 26, 2024 | clinicaltrials |
| NCT05007938 | Befotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung Cancer | unknown | Phase 2 | 30 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Aug 23, 2024 | clinicaltrials |
| NCT05336318 | Peer2Me: A Peer Supported Program for Adolescent and Young Adult Cancer Patients(Peer2Me) | unknown | N/A | 180 | University of LeipzigOTHER | 1 | Aug 23, 2024 | clinicaltrials |
| NCT05341583 | Ensartinib as Adjuvant Treatment in Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung Cancer | unknown | Phase 3 | 202 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Aug 23, 2024 | clinicaltrials |
| NCT06224387 | CTS2190 Phase I /II Clinical Study in Patients | unknown | Phase 1 / Phase 2 | 224 | CytosinLab Therapeutics Co., Ltd.INDUSTRY | 1 | Aug 23, 2024 | clinicaltrials |
| NCT06496711 | IMPLEMENT - Model Project for Quality-assured Exercise Therapy for Cancer Patients | unknown | N/A | 600 | University of CologneOTHER | 1 | Aug 23, 2024 | clinicaltrials |
| NCT06565585 | Prediction of Local Recurrence and Its Impact on Long-term Outcomes After Low-risk Glans-sparing Surgery for Penile Squamous Cell Carcinoma | unknown | — | 800 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Aug 23, 2024 | clinicaltrials |
| NCT00877214 | Significance of Duration of Maintenance Therapy With Rituximab in Non-Hodgkin Lymphomas(MAINTAIN) | unknown | Phase 3 | 1,272 | Jurgen BarthOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT02949219 | Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery | unknown | Phase 2 | 41 | Academic and Community Cancer Research UnitedOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT04185831 | A MolEcularly Guided Anti-Cancer Drug Off-Label Trial(MEGALiT) | unknown | Phase 2 | 167 | Uppsala University HospitalOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT05887102 | Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors(PACHA) | unknown | N/A | 66 | CHU de Quebec-Universite LavalOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT06404281 | γδ T-PD-1 Ab Cells in the Treatment of Advanced Solid Tumors | unknown | Phase 1 | 9 | Changzhou No.2 People's HospitalOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT06425146 | Tobacco, Alcohol and Cancerization of the Oral Mucosa (TACO)(TACO) | unknown | N/A | 30 | Centre Leon BerardOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT06463756 | AI Models to Predict Thyroid Cartilage Invasion in Laryngeal Carcinoma | unknown | — | 400 | First Affiliated Hospital of Chongqing Medical UniversityOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT06565923 | Study on the Staging and Prognosis Model of Bladder Cancer(2024-SR-386) | unknown | — | 200 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT06566391 | Ipilimumab and Nivolumab Followed by Adjuvant Nivolumab in Locally Advanced or Limited Metastatic Melanoma | unknown | Phase 2 | 35 | European Institute of OncologyOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT06566560 | The ROAD 2.0 to Sustainable Medication Use: Redispensing Unused Oral Anticancer Drugs | unknown | N/A | 2,500 | Radboud University Medical CenterOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT03424343 | Longitudinal Identity Study of Childhood Cancer Survivors(LInC) | unknown | — | 126 | KU LeuvenOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT03748550 | Exercise to Prevent AnthraCycline-based Cardio-Toxicity Study 2.0 (EXACT2)(EXACT2) | unknown | N/A | 7 | Nova Scotia Health AuthorityOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT04741906 | Outcome of Dental Implant Therapy in Patients Treated With Antiresorptive Medication | unknown | — | 225 | Copenhagen University Hospital at HerlevOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT05024162 | Can MRI of the Prostate Combined With a Radiomics Evaluation Determine the Invasive Capacity of a Tumour(MRI-PREDICT) | unknown | N/A | 60 | Nova Scotia Health AuthorityOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT05106725 | Wearable Devices and Biomarkers Project (Healthiomics) | unknown | — | 3,500 | CureScienceOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT05229614 | Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease(ICONIC) | unknown | Phase 2 | 27 | CNAO National Center of Oncological HadrontherapyOTHER | 2 | Aug 21, 2024 | clinicaltrials |
| NCT05452668 | Laser Therapy Effect on Oral Mucositis in Childhood Acute Lymphoblastic Leukemia Patients | unknown | N/A | 51 | Children's Cancer Hospital Egypt 57357OTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT05501899 | Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia | unknown | Early Phase 1 | 20 | Children's Hospital of Orange CountyOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT05972785 | Long-term Use of CCB and Breast Cancer Risk | unknown | — | 68,500 | Curtin UniversityOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT06149169 | CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma | unknown | Phase 2 | 10 | Shanghai Ming Ju Biotechnology Co., Ltd.INDUSTRY | 1 | Aug 21, 2024 | clinicaltrials |
| NCT06564363 | The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma | unknown | — | 148 | Wuhan Ammunition Life-tech Co., LtdINDUSTRY | 1 | Aug 21, 2024 | clinicaltrials |
| NCT06564870 | Efficacy and Safety Study of DURVALUMAB Maintenance in Patients With Stage III Non-Small Cell Lung Cancer(DURVABREIZH) | unknown | — | 200 | University Hospital, BrestOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT05169853 | Programmed Death-Ligand1 Expression in Her-2 Positive and Triple Negative Breast Cancer | unknown | — | 80 | Ain Shams UniversityOTHER | 1 | Aug 20, 2024 | clinicaltrials |
| NCT05947903 | Validation of the European Oncology Quality of Life Toolkit | unknown | — | 4,000 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 32 | Aug 20, 2024 | clinicaltrials |
| NCT06215976 | The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer | unknown | Phase 4 | 78 | Cairo UniversityOTHER | 1 | Aug 20, 2024 | clinicaltrials |
| NCT06562517 | Digital Training Module for Sustainable Education of Pediatric Oncology Nurses | unknown | N/A | 104 | Koç UniversityOTHER | 1 | Aug 20, 2024 | clinicaltrials |
| NCT03612232 | Cabozantinib in Advanced Adrenocortical Carcinoma(CaboACC) | unknown | Phase 2 | 37 | Wuerzburg University HospitalOTHER | 1 | Aug 19, 2024 | clinicaltrials |
| NCT04304066 | Research for the Molecular Imaging of the PD-L1 Targeting Tracer | unknown | N/A | 50 | Peking University Cancer Hospital & InstituteOTHER | 1 | Aug 19, 2024 | clinicaltrials |
| NCT04560725 | PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate Cancer | unknown | N/A | 50 | Peking University Cancer Hospital & InstituteOTHER | 1 | Aug 19, 2024 | clinicaltrials |
| NCT04596670 | 68Ga-ICAM-1pep PET/CT in Cancer Patients | unknown | Early Phase 1 | 20 | Peking University Cancer Hospital & InstituteOTHER | 1 | Aug 19, 2024 | clinicaltrials |
| NCT06558903 | Searching for Predictive Biomarkers of Efficacy in Small Cell Lung Cancer Patients Treated With Chemotherapy-immunotherapy Combination Using Imaging Mass Cytometry (HYPE)(HYPE) | unknown | — | 20 | University Hospital, BrestOTHER | 1 | Aug 19, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Aug 27, 2024source: clinicaltrials